Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Sees Significant Decline in Short Interest

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 4,300 shares, a drop of 23.2% from the November 15th total of 5,600 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 43.0 days.

Laboratorios Farmaceuticos Rovi Price Performance

LABFF remained flat at C$65.86 during trading on Friday. The firm has a 50 day moving average price of C$83.68 and a 200 day moving average price of C$87.42. Laboratorios Farmaceuticos Rovi has a twelve month low of C$65.86 and a twelve month high of C$65.86.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.